Research Impact

h-index

N/A

Research impact score

Publications

0

Total publications

Trial Results

0

Published trial results

Citations

0

Total citations

Drug Portfolio

Analytics

Trial Phases

Phase 21

Trial Status

Other1

Role Distribution

Principal Investigator1
PI Rate100%

Activity Timeline

Clinical Trials (1)

NCT02766868Phase 2Unknown
Sequential Intensive Chemotherapy Followed by RIC for Refractory and Relapse ALL
Lymphoblastic Leukemia, Acute, Adult
Principalinvestigator

Research Network

Collaboration Network

1 collaborators·0 connections
Network Legend
KOL
Current Investigator
CO
High-influence Collaborator
CO
Collaborator
Click: view details
Double-click: go to profile
Drag: move node

Research Areas & Affiliations

Affiliations

Rui Jin Hospital, Shanghai JiaoTong University School of Medicine

Similar Key Opinion Leaders

Discover other key opinion leaders with similar research profiles, therapeutic areas, and collaboration networks.

10 similar investigators found

Allen Yeoh, M.D

National University Hospital, Singapore

Moderately Similar
2 trials

Shared therapeutic areas:

Leukemia, Lymphocytic, Acute, L2
Similarity Score30%

Alicia Kunin-Batson, Ph.D.

Masonic Cancer Center, University of Minnesota

Moderately Similar
1 trials

Shared therapeutic areas:

Leukemia, Lymphocytic, Acute, L2
Similarity Score30%

Cyril Salek, MD

Institute of Hematology and Blood Transfusion, Czech Republic

Moderately Similar
2 trials

Shared therapeutic areas:

Leukemia, Lymphocytic, Acute, L2
Similarity Score30%

Dario Campana, M.D, PhD

National University of Singapore

Moderately Similar
2 trials

Shared therapeutic areas:

Leukemia, Lymphocytic, Acute, L2
Similarity Score30%

Guillermo Sanz, Doctor

Hospital Universitario La Fe

Moderately Similar
1 trials

Shared therapeutic areas:

Leukemia, Lymphocytic, Acute, L2
Similarity Score30%

Wing Hang Leung, MD PhD

KK Women's and Children's Hospital, BMTCT

Moderately Similar
1 trials

Shared therapeutic areas:

Leukemia, Lymphocytic, Acute, L2
Similarity Score30%

Suning Chen, M.D., Ph.D.

First Affiliated Hospital of Suzhou Medical College

Moderately Similar
1 trials

Shared therapeutic areas:

Leukemia, Lymphocytic, Acute, L2
Similarity Score30%

Michaela Seng, MD

KK Women's and Children's Hospital, BMTCT

Moderately Similar
1 trials

Shared therapeutic areas:

Leukemia, Lymphocytic, Acute, L2
Similarity Score30%

David Ritchie

Melbourne Health

Moderately Similar
1 trials

Shared therapeutic areas:

Leukemia, Lymphocytic, Acute, L2
Similarity Score30%

Weili Zhao, M.D., Ph.D.

Shanghai Jiaotong University School of Medicine Ruijin Hospital

Moderately Similar
1 trials

Shared therapeutic areas:

Leukemia, Lymphocytic, Acute, L2
Similarity Score30%

Publications (0)

No publications found for this investigator.

Clinical Trials (1)

Showing 1 of 1 trials

NCT02766868Phase 2PrincipalInvestigator

Sequential Intensive Chemotherapy Followed by RIC for Refractory and Relapse ALL

Lymphoblastic Leukemia, Acute, Adult
Unknown

All 1 trials loaded